CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

First patient free of cancer: This stock to benefit from big breakthrough in cancer treatment - Indigenous CAR-T cell therapy!

India's entry into the CAR T-cell therapy arena marks a pivotal moment in the global fight against cancer.

Karan Dsij 0 1842 Article rating: 3.9

In this landscape of innovation, companies like Laurus Lab Ltd stand out as key players driving progress in the transformative cell and gene therapy space. Their strategic collaborations and advancements in product development hold promise for improving treatment outcomes and enhancing accessibility for patients

This mid-cap multibagger Pharma company signs MOA with IIT Kanpur for novel gene therapy assets!

The company delivered exceptional returns of 251 per cent over the past 3 years.

Siddharth Mane 0 11372 Article rating: 3.8

The company delivered exceptional returns of 251 per cent over the past 3 years, while over the past 5 years, it provided remarkable returns of 242 per cent.    

This mid-cap multibagger company invests in cell and gene therapy company ImmunoACT!

Through this collaboration, the company aims to bring CAR-T therapy to Indian patients at an affordable price, filling the gap in access to this novel treatment option.

Siddharth Mane 0 9755 Article rating: 3.3

CAR-T therapy has shown significant success in the western world as a promising treatment option. However, this innovative technology is currently unavailable in India. Through this collaboration, the company aims to bring CAR-T therapy to Indian patients at an affordable price, filling the gap in access to this novel treatment option. 

All eyes here: Futures and Options traders must take note of these changes!

While these changes will be effective from October 28 (a day after October expiry), the contracts, for which they will be applicable, will vary. Here is a quick summary: 

Karan Dsij 0 2254 Article rating: 4.5

As per NSE circular dated September 30, a total of 37 stocks will see changes in their F&O lot sizes due to the relevant price movements.  

Stocks to watch: These small-cap stocks will be in focus tomorrow!

Pitti Engineering, Sree Rayalaseema Hi-Strength Hypo, Shoppers Stop, Archidply Industries, Vinyl Chemicals (India), Superhouse, International Constructions, Kirloskar Electric, Kritika Wires, PVR and Madhya Bharat Agro Products made a fresh 52-week high today

Armaan Madhani 3 3452 Article rating: 4.2

BSE Smallcap index surged 0.38 per cent to end the session at 26,517.8.

Stocks below Rs 100: Only buyers seen in these scrips on April 28

On Thursday around noon, the core equity indices i.e., Sensex and Nifty 50 were trading higher by a per cent each amidst mixed cues in the global markets. US Stock futures climbed in the overnight trade as the market recovered from its April sell-off and investors reacted favourably to Meta Platforms' profits.

Sayali Kotwal 0 1027 Article rating: 5.0

On Thursday around noon, the core equity indices i.e., Sensex and Nifty 50 were trading higher by a per cent each amidst mixed cues in the global markets.  US Stock futures climbed in the overnight trade as the market recovered from its April sell-off and investors reacted favourably to Meta Platforms' profits.  Dow Jones Industrial Average futures rose 70 points or 0.2 per cent. Futures on S&P 500 increased by 0.7 per cent while Nasdaq 100 futures increased by 1.2 per cent.  

Overnight Digest: Stocks to watch out on March 14

Cipla, BPCL, Sun Pharma, JSW Steel and IOC were among the top Nifty gainers, while losers were Nestle India, Maruti Suzuki, Tata Consumer Products, Hindalco Industries and NTPC.

Shreya Chaware 0 1084 Article rating: 4.9

On Friday, the domestic benchmark indices remained range-bound due to cautiousness on the back of rising cost pressures on corporates, increase in global inflation globally and sluggish automobile dispatches to dealers due to supply constraints. 

Overnight Digest: Keep these stocks on your radar for January 24

Weak sentiments from global markets due to continuous inflationary worries and weaker earnings also contributed to the selling pressure.

Shreya Chaware 0 1711 Article rating: 4.4

The ongoing selling by FIIs and weak Indian rupee led the domestic market to continue surrendering its gains, with all major sectors trading under pressure. 

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR